Eledon Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Eledon Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Eledon Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $102K, a 22.9% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $378K, a 2.33% decline from 2022.
  • Eledon Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $387K, a 86.1% increase from 2021.
  • Eledon Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $208K, a 10.6% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $102K +$19K +22.9% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-08-19
Q1 2023 $83K -$14K -14.4% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-08-19
Q1 2022 $97K +$48K +98% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $49K +$2K +4.26% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $47K +$2K +4.44% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-15
Q1 2019 $45K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.